TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Reviews on Recent Clinical Trials · 01.01.2009 · 4 (1) · 34-41
DOI: 10.2174/157488709787047530 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews on Recent Clinical Trials, erschienen am 01.01.2009. Verfasst von Anita C Bellail und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, 1365-C Clifton Road, Atlanta, GA, USA. Die Arbeit wurde bisher 135-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, 1365-C Clifton Road, Atlanta, GA, USA.
Zitieren
APA
Bellail, A. C., Qi, L., Mulligan, P., Chhabra, V., & Hao, C. (2009). TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges. Reviews on Recent Clinical Trials, 4(1), 34-41. https://doi.org/10.2174/157488709787047530
Vancouver
Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C. TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges. Reviews on Recent Clinical Trials. 2009;4(1):34-41. doi:10.2174/157488709787047530
BibTeX
@article{Bellail2009,
author = {Bellail, Anita C and Qi, Ling and Mulligan, Patrick and Chhabra, Vaninder and Hao, Chunhai},
title = {TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges},
journal = {Reviews on Recent Clinical Trials},
year = {2009},
volume = {4},
number = {1},
pages = {34--41},
doi = {10.2174/157488709787047530}
}
EUVIMED